Notice of Correction and the Change of the Receipt Date for PAR-21-125 Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed); PAR-21-126 High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed); PAR-21-127 Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Notice Number:
NOT-OD-21-136

Key Dates

Release Date:

May 26, 2021

Related Announcements

PAR-21-125 - Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)

PAR-21-126 - High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

PAR-21-127 - Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

Issued by

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Purpose

1) This Notice alerts applicants that the PHS Human Subjects and Clinical Trials Information form and the budget forms are not applicable and should not be included in the application submission package for the following FOAs:

PAR-21-125 Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed),

PAR-21-126 High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed), and

PAR-21-127 Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

Accordingly, the text of PAR-21-125, PAR-21-126, and PAR-21-127 is modified as follows:

Originally Published Version

R&R Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

R&R Subaward Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

PHS 398 Cover Page Supplement

All instructions in the SF424 (R&R) Application Guide must be followed.

Resource Sharing Plan:

Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide.

Appendix:

Appendix materials are not allowed for this FOA.

PHS Human Subjects and Clinical Trials Information

When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:

If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the SF424 (R&R) Application Guide must be followed.

Delayed Onset Study

Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start).All instructions in the SF424 (R&R) Application Guide must be followed.

Corrected Version (changes are shown below in italics and underlined)

PHS Human Subjects and Clinical Trials Information

Not applicable.

R&R Budget

Not applicable.

R&R Subaward Budget

Not applicable.

PHS 398 Cover Page Supplement

All instructions in the SF424 (R&R) Application Guide must be followed.

Resource Sharing Plan:

Not applicable.

Appendix:

Appendix materials are not allowed for this FOA.

PHS Human Subjects and Clinical Trials Information

Not applicable.

2. As a result of these corrections, this Notice extends the receipt date by 2 weeks, to June 15, 2021.

Originally Published Version

Application Due Dates

New

June 01, 2021

Renewal / Resubmission / Revision (as allowed)

June 01, 2021

Corrected Version (changes are shown below in italics and underlined)

Application Due Dates

New

June 15, 2021

Renewal / Resubmission / Revision (as allowed)

June 15, 2021

Inquiries

Please direct all inquiries to:

Alena Horska, PhD
Office of Research Infrastructure Programs (ORIP)
Telephone: 301-435-0772
Email: [email protected]v

Guanghu Wang, PhD, MBA
Office of Research Infrastructure Programs (ORIP)
Telephone: 301-435-0772
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices